Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel SNX8-BRAF Gene Fusion.
Katharine OfferMichael T McGuireKunchang SongMichael J GoldfischerMonika A DavareChristopher L CorlessCarol BeadlingTanaya NeffMichael C CoxSandya Govinda RajuSamuel C BlackmanPublished in: JCO precision oncology (2023)